NCT02547740View on ClinicalTrials.gov

Macular Damage in Early Glaucoma and Progression

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 18, 2024

Study Completion Date

January 18, 2024

Conditions
Glaucoma
Trial Locations (1)

10032

CUIMC Harkness Eye Institute, New York

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Columbia University

OTHER

NCT02547740 - Macular Damage in Early Glaucoma and Progression | Biotech Hunter | Biotech Hunter